About the Authors

Marc D. de Smet

mddesmet1@mac.com

Affiliations MicroInvasive Ocular Surgery Center (MIOS sa), Lausanne, Switzerland, Preceyes nv, Einhoven, The Netherlands

Thijs C. M. Meenink

Affiliation Preceyes nv, Einhoven, The Netherlands

Tom Janssens

Affiliation ThromboGenics nv, Leuven, Belgium

Valerie Vanheukelom

Affiliation ThromboGenics nv, Leuven, Belgium

Gerrit J. L. Naus

Affiliation Preceyes nv, Einhoven, The Netherlands

Maarten J. Beelen

Affiliation Preceyes nv, Einhoven, The Netherlands

Caroline Meers

Affiliation Medanex Clinic BVBA, Diest, Belgium

Bart Jonckx

Affiliation ThromboGenics nv, Leuven, Belgium

Jean-Marie Stassen

Affiliation Crystapharm BVBA, Lubbeek, Belgium

Competing Interests

MDdS received grant support from TG and is a patent holder (without royalty) of ocriplasmin. He is also a founding member and chief medical officer of Preceyes NV.

Author Contributions

Conceived and designed the experiments: MDdS BJ JMS. Performed the experiments: MDdS TJ VV CM MJB TCMM. Analyzed the data: BJ MDdS GJLN TCMM MJB. Contributed reagents/materials/analysis tools: BJ. Wrote the paper: MDdS BJ TCMM GJLN.